CDC-defined diseases and opportunistic infections in Jamaican children with HIV/AIDS

West Indian Medical Journal

Volumn 53, Issue 5, 2004, Pages 315-321

  Pierre, R ^a   Steel Duncan, J C ^a   Evans Gilbert, T ^a   Rodriguez, B ^a   Palmer, P ^a   Smikle, M F ^a   Whorms, S ^a   Hambleton, I ^a   Figueroa, J P ^a   Christie, Celia D C ^a  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIRETROVIRUS AGENT; ATOVAQUONE; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; PENTAMIDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; AMBULATORY CARE; ARTICLE; BACTERIAL INFECTION; BRAIN DISEASE; CARIBBEAN ISLANDS; CHILD; CHILD DEATH; CLINICAL OBSERVATION; CLINICAL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DERMATITIS; DIARRHEA; ESCHERICHIA COLI; FEMALE; HEALTH PROGRAM; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFECTION CONTROL; JAMAICA; LUNG TUBERCULOSIS; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; OPPORTUNISTIC INFECTION; PATHOGENESIS; PEDIATRIC HOSPITAL; PERINATAL INFECTION; PNEUMOCYSTIS PNEUMONIA; PROSPECTIVE STUDY; SEPSIS; STREPTOCOCCUS PNEUMONIAE; SUPERINFECTION; SYMPTOMATOLOGY; UNIVERSITY HOSPITAL; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; VERTICAL TRANSMISSION; WASTING SYNDROME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HUMANS; INFANT; JAMAICA; MALE; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 10644256515     PISSN: 00433144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Joint United Nations Programme on HIV/AIDS (UNAIDS) 2003. Fact sheet, Latin America and the Caribbean, http://www.unaids.org/html/pub/publications/Fact-sheets03/ FS_LAC_en_pdf.htm, accessed 09/12/2003.
2. Cameron E, Barton EN, Robert LS, Bartholomew C. Paediatric acquired immune deficiency syndrome. Report on the first case in Trinidad. West Indian Med J 1986; 35: 61-2.
3. Figueroa PJ, Braithwaite A, Ward E, Ducasse M, Tscharf I, Nembhard O, et al. The HIV/AIDS epidemic in Jamaica. AIDS 1995; 9: 761-8.
4. Christie C, Bain B, Pierre R, Smikle MF, Evans-Gilbert T, Fredericks J et al. HIV/AIDS in women, infants, children and adolescents in Jamaica: a further "call to action". West Indian Med J 2001; 50 258-62.
5. Luzuriaga K, Sullivan JL. Pediatric HIV-1 infection: advances and remaining challenges. AIDS Rev 2002; 4: 21-6.
6. Jamaica Ministry of Health. Jamaica AIDS report 2002, Facts and Figures http://www.nacjamaica.com/aids_hiv/facts_figures.htm accessed 07/09/2003.
7. Barnhart H, Caldwell MB, Thomas P, Mascola L, Ortiz I, Hsu H et al. Natural history of human immunodeficiency virus disease in perinatally infected children: an analysis from the Pediatric Spectrum of Disease Project. Pediatrics 1996; 97: 710-6.
8. Natural history of vertically acquired immunodeficiency virus-1 infection. The European Collaborative Study. Pediatrics 1994; 94: 815-9.
9. Features of children perinatally infected with HIV-1 surviving longer than 5 years. Italian register for HIV infection in children. Lancet 1994; 343: 191-5.
10. Blanche S, Tardieu M, Duliege A, Rouzioux C, Le Deist F, Fukunaga K et al. Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection: evidence for a bimodal expression of clinical and biological symptoms. Am J Dis Child 1990; 144: 1210-5.
11. Kuhn L, Thomas PA, Singh T, Tsai WY. Long-term survival of children with human immunodeficiency virus infection in New York City: estimates from population-based surveillance data. Am J Epidemiol 1998; 147: 846-54.
12. Spira R, Lepage R, Msellati P, Van de Perre P, Leroy V, Simonon A et al. Natural history of human immunodeficiency virus type 1 infection in children: a five year prospective study in Rwanda. Mother to child HIV-1 transmission study group. Pediatrics 1999; 104: 56.
13. Henry G, Chong J, Bratt DE, Cameron E. Paediatric acquired immunodeficiency syndrome (PAIDS) in Trinidad and Tobago. West Indian Med J 1990; 39: 174-7.
14. Jean SS, Reed GW, Verdier RI, Pape JW, Johnson WD, Wright PF. Clinical manifestations of human immunodeficiency virus infection in Haitian children. Pediatr Infect Dis J 1997; 16: 600-6.
15. Kumar A, St John MA. HIV infection among children in Barbados. West Indian Med J 2000; 49: 43-6.
16. St John MA, Kumar A, Cave C. Reduction in perinatal transmission and mortality from human immunodeficiency virus after intervention with zidovudine in Barbados. Pediatr Infect Dis J 2003; 22: 422-6.
17. Evans-Gilbert T, Hambleton I, McKenzie CA, Samms-Vaughan M. Paediatric HIV/AIDS in Jamaica. A hospital-based description. West Indian Med J 2002; 51: 74-9.
18. Christie CDC. A Paediatric and Perinatal HIV/AIDS Leadership Initiative in Kingston, Jamaica. West Indian Med J 2004; 53: 283-92.
19. Centers for Disease Control. 1987 revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987; 36: 1-15.
20. Palmer P, Anderson-Allen MM, Billings CC, Moore JT, McDonald-Kerr C, Steel-Duncan JC et al. Nursing interventions in the Kingston Paediatric and Perinatal HIV/AIDS Programme. West Indian Med J 2004; 53: 327-31.
21. Centers for Disease Control. 1994 revised classification system for HIV infection in children less than 13 years of age. MMWR 1994; 43: 1-10.
22. Centers for Disease Control. 1993 revised classification system for HIV infection and expanded case surveillance definition for AIDS among adolescents and adults. MMWR 1993; 41:1-19.
23. Stata Corporation 2001. Stata statistical software: Release 7.0 College Station TX; Stata Corporation.
24. Steel-Duncan JC, Pierre R, Evans-Gilbert T, Rodriguez B, Smikle MF, Palmer P et al. Uptake of interventions, outcomes and challenges in caring for HIV-exposed infants in Kingston, Jamaica. West Indian Med J 2004; 53: 308-14.
25. Rodriguez B, Steel-Duncan JC, Pierre R, Evans-Gilbert T, Hambleton I, Palmer P et al. Socio-demographic characteristics of HIV-exposed and HIV-infected Jamaican children. West Indian Med J 2004; 53: 303-7.
26. Evans-Gilbert T, Pierre R., Steel-Duncan JC., Rodriguez B, Whorms S, Hambleton IR et al. Anti-retroviral drug therapy in HIV-infected Jamaican Children. West Indian Med J 2004; 53: 322-6.
27. Joint United Nations Programme On HIV/AIDS (UNAIDS) And United Nations Children's Fund (UNICEF) (2002). Children on the Brink 2002. A Joint Report on Orphan Estimates and Program Strategies-July 2002. Accessed 12/07/2002.
28. Vetter KM, Djomand G, Zadi F, Diaby L, Brattegard K, Timite M et al. Clinical spectrum of human immunodefidiency virus disease in a West African city. Pediatr Inf Dis J 1996; 15: 438-42.
29. Hira SK, Kamanga J, Bhat GJ, Mwale C, Tembo G, Luo N, Perine PL. Perinatal transmission of HIV-1 in Zambia. BMJ 1989; 299 1250-2.
30. Lepage P, Van de Perre P, Van Vliet G, Nsengumuremyi F, Van Goethem C, Kestelyn P et al. Clinical and endocrinologic manifestations in perinatally human immunodeficiency virus type 1-infected children aged 5 years or older. Am J Dis Child 1991; 145: 1248-51.
31. Dankner WM, Lindsay JC, Levin MJ and the Pediatric AIDS Clinical Trials Group Protocol Teams 051, 128, 138, 144, 152, 179, 190, 220, 240, 245, 254, 300, and 327. Correlates of opportunistic infections in children infected with the human immunodeficiency virus managed before highly active antiretroviral therapy. Pediatr Infect Dis J 2001; 20 40-8.
32. Nicholson AM, Rainford L, Elliott V, Christie CDC. Disseminated histoplasmosis and AIDS at the University Hospital of the West Indies. A case report. West Indian Med J 2004; 53: 126-30.
33. Intravenous immune globulin for the prevention of bacterial infections in children with symptomatic human immunodeficiency virus infections. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Study Group. N Engl J Med 1991; 325: 73-80.
34. Spector SA, Gelber RD, McGrath N, Wara D, Barzilai A, Abrams E, et al. A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group. N Engl J Med 1994; 331: 1181-7.
35. Madhi SA, Petersen K, Madhi A, Wasas A, Klugman KP. Impact of human immunodeficiency virus type 1 on the disease spectrum of Streptococcus pneumoniae in South African children. Pediatr Infect Dis J 2000; 19: 1141-7.
36. Lichenstein R, King JC Jr, Farley JJ, Su P, Nair P, Vink PE. Bacteremia in febrile human immunodeficiency virus-infected children presenting to ambulatory care settings. Pediatr Infect Dis J 1998; 17 381-5.
37. Farley JJ, King JC Jr, Nair P, Hines SE, Tressler RL, Vink PE, Invasive pneumococcal disease among infected and uninfected children of mothers with human immunodeficiency virus infection. J Pediatr 1994; 124: 853-8.
38. Andiman WA, Simpson J, Holtkamp C, Pearson HA. Invasive pneumococcal infections in children infected with HIV are not associated with splenic dysfunction. AIDS Pat Care STDS 1996; 10: 336-41.
39. McGregor D, Barton M, Thomas S, Christie CD. Invasive pneumococcal disease in Jamaican children. Ann Trop Paediatr 2004; 24 33-40.
40. Knight-Madden J, Serjeant GR. Invasive pneumococcal disease in homozygous sickle cell disease: Jamaican experience 1973-1997. J Pediatr 2001; 138: 65-70.
41. Rongkavilit C, Rodriguez ZM, Gomez-Marin O, Scott GB, Hutto C, Rivera-Hernandez DM et al. Gram-negative bacillary bacteremia in human immunodeficiency virus type 1-infected children. Pediatr Infect Dis J 2000; 19:122-8.
42. Allen U, Thomas S, Carapetis J, Henry S Wasfy S, Lovgren M, Richardson S et al. Serotypes of respiratory tract isolates of streptococcus pneumoniae from Jamaican children. Int J Infec Dis 2003; 7: 29-34.
43. Christie CD, Duncan N, Thame K, Heaton P, Onorato MT, Dallas M et al. Rotavirus Efficacy and Safety Trial (REST) in Jamaica: Evaluation of an Investigational Rotavirus Vaccine. Vaccines for Enteric Diseases, 4th International Conference, Jamaica, June 2004, abstr 146.
44. Peters V, Liu K-L, Dominguez K, Frederick T, Melville S, Hsu H-W et al. Missed opportunities for perinatal HIV prevention among HIV-exposed infants born 1996-2000, Pediatric Spectrum of HIV Disease Cohort. Pediatrics 2003; 111: 1186-91.